FDA Adverse Event Malfunction Summary report: N

CYTOKERATIN FRAGMENTS 21-1 EIA KIT

MDR report key: 9878349 · Received March 25, 2020

Report

Report Number
1823260-2020-00838
Event Type
Malfunction
Date Received
March 25, 2020
Date of Event
February 15, 2020
Report Date
April 14, 2020
Manufacturer
ROCHE DIAGNOSTICS
Product Code
OVK
PMA / PMN Number
K160915
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
HR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

QC RESULTS DO NOT INDICATE A REAGENT ISSUE. THE CUSTOMER COULD NOT PROVIDE THE PATIENT'S SAMPLE FOR FURTHER TESTING TO COMPLETE THE INVESTIGATION. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT OR INSTRUMENT PROBLEM. THE CAUSE OF THE EVENT COULD NOT BE DETERMINED.

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6). THE FIELD SERVICE ENGINEER DID NOT IDENTIFY A PRODUCT PROBLEM. HE RECOMMENDED THE CUSTOMER USE A NEW REAGENT CASSETTE AND PERFORM CALIBRATION AND QC WITH FRESH MATERIALS. THE FIELD APPLICATIONS SPECIALIST PERFORMED A PRECISION CHECK.

Description of Event or Problem · 1

THE INITIAL REPORTER RECEIVED QUESTIONABLE CYFRA 21-1 ELECSYS RESULTS FOR ONE PATIENT ON A COBAS E411 RACK SERIAL NUMBER (B)(4) AND A COBAS 8000 E 801 MODULE, SERIAL NUMBER REQUESTED BUT NOT PROVIDED. THE INITIAL RESULTS FROM AN E411 WERE NOT REPORTED OUTSIDE THE LABORATORY. THE CUSTOMER SENT THE PATIENT¿S SAMPLE TO ANOTHER LABORATORY FOR REPEAT TESTING ON AN E 801.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
340879 CYTOKERATIN FRAGMENTS 21-1 EIA KIT TUMOR-ASSOCIATED ANTIGEN IMMUNOLOGICAL TEST SYSTEM. OVK ROCHE DIAGNOSTICS NA 422890

Patients

Seq Age Sex Outcome Treatment
1